Literature DB >> 6724533

Histopathology of gastric carcinoids: a survey of 42 cases.

E Wilander, M El-Salhy, P Pitkänen.   

Abstract

An unselected series of 42 gastric carcinoids has been reviewed. Clinically the tumours simulated common gastric lesions including ulcer, polyp and carcinoma. No endocrine symptoms were identified. The tumours were most frequent in the body of the stomach and in 25% in that site were multiple. Morphologically most tumours when classified according to Soga (1974) demonstrated a mixed growth pattern. Six tumours displayed an atypical morphology (type D): they were larger and metastasized more frequently than the rest of the tumours. Six tumours contained a few scattered argentaffinic cells but the others were negative indicating negligible serotonin secretion in only a few cases. The Grimelius argyrophilic reaction was positive in most cells in all tested tumours except in three, two of which showed atypical morphology (type D). It is suggested that gastric carcinoids with a type D morphology or a minority cell population of argyrophil cells are dedifferentiated carcinoids which are biologically nearer to gastric carcinomas. The most frequent clinicopathological correlation was achlorhydria linking pernicious anaemia and gastric carcinoids. This indicates pathogenetic similarities between gastric carcinoids and gastric carcinomas.

Entities:  

Mesh:

Year:  1984        PMID: 6724533     DOI: 10.1111/j.1365-2559.1984.tb02335.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  15 in total

1.  Calbindin immunoreactivity is a characteristic of enterochromaffin-like cells (ECL cells) of the human stomach.

Authors:  J B Furness; R T Padbury; K G Baimbridge; J M Skinner; D E Lawson
Journal:  Histochemistry       Date:  1989

2.  Two cases of gastric carcinoids: diagnostic and therapeutic aspects.

Authors:  H Ahlman; A Dahlström; L Enerbäck; G Granérus; O Nilsson; S Persson; L E Tisell
Journal:  World J Surg       Date:  1988-06       Impact factor: 3.352

Review 3.  Achlorhydria: hypergastrinaemia: carcinoids--a flawed hypothesis?

Authors:  J Penston; K G Wormsley
Journal:  Gut       Date:  1987-04       Impact factor: 23.059

Review 4.  Gut endocrine and neural peptides.

Authors:  Anne E Bishop; Julia M Polak
Journal:  Endocr Pathol       Date:  1990-03       Impact factor: 3.943

5.  Clinical symptoms, hormone profiles, treatment, and prognosis in patients with gastric carcinoids.

Authors:  D Granberg; E Wilander; M Stridsberg; G Granerus; B Skogseid; K Oberg
Journal:  Gut       Date:  1998-08       Impact factor: 23.059

6.  Association of long lasting unsurmountable histamine H2 blockade and gastric carcinoid tumours in the rat.

Authors:  D Poynter; C R Pick; R A Harcourt; S A Selway; G Ainge; I W Harman; N W Spurling; P A Fluck; J L Cook
Journal:  Gut       Date:  1985-12       Impact factor: 23.059

7.  Pernicious anaemia and mucosal endocrine cell proliferation of the non-antral stomach.

Authors:  J Rode; A P Dhillon; L Papadaki; R Stockbrügger; R J Thompson; E Moss; P B Cotton
Journal:  Gut       Date:  1986-07       Impact factor: 23.059

Review 8.  Omeprazole. Gastrin and gastric endocrine cell data from clinical studies.

Authors:  R G Berlin
Journal:  Dig Dis Sci       Date:  1991-02       Impact factor: 3.199

9.  Carcinoid tumour of stomach and primary hyperparathyroidism: a new association.

Authors:  J Rode; A P Dhillon; P B Cotton; A Woolf; J L O'Riordan
Journal:  J Clin Pathol       Date:  1987-05       Impact factor: 3.411

10.  Comparison of immunological detection of 5-hydroxytryptamine by monoclonal antibodies with standard silver stains as an aid to diagnosing carcinoid tumours.

Authors:  P A Shaw
Journal:  J Clin Pathol       Date:  1988-03       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.